Tenaya Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$29.32 | $1.59 B | -7.1 | 60 | $0 |
ALXO
ALX Oncology Holdings Inc. |
$1.60 | $469.42 M | -2.43 | 89 | $0 |
BCYC
Bicycle Therapeutics plc |
$14.71 | $982.26 M | -5.24 | 284 | $26.98 M |
BMEA
Biomea Fusion, Inc. |
$4.23 | $148.81 M | -1.17 | 107 | $0 |
CRVS
Corvus Pharmaceuticals, Inc. |
$5.00 | $126.98 M | -3.98 | 28 | $0 |
DRTS
Alpha Tau Medical Ltd. |
$3.10 | $170.30 M | -5.95 | 121 | $0 |
EYEN
Eyenovia, Inc. |
$0.09 | $40.94 M | -1.03 | 57 | $3,787 |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.91 | $243.38 M | -1.59 | 133 | $0 |
GOSS
Gossamer Bio, Inc. |
$0.84 | $124.06 M | -0.65 | 135 | $0 |
IGMS
IGM Biosciences, Inc. |
$6.90 | $485.17 M | -1.95 | 198 | $2.13 M |
INZY
Inozyme Pharma, Inc. |
$2.98 | $286.39 M | -3.43 | 59 | $0 |
OCUL
Ocular Therapeutix, Inc. |
$8.50 | $765.15 M | -4.41 | 267 | $58.44 M |
RANI
Rani Therapeutics Holdings, Inc. |
$1.41 | $221.34 M | -3.4 | 140 | $0 |
STOK
Stoke Therapeutics, Inc. |
$11.65 | $774.50 M | -6.14 | 110 | $8.78 M |
VINC
Vincerx Pharma, Inc. |
$0.21 | $21.03 M | -0.4 | 42 | $0 |